June 2025
Factsheets
Quarterly Reviews
Amati Insights
Additional Monthly Highlights

Medical diagnostics is an exciting growth area. Demand for diagnostics from patients and health professionals is combined with and amplified by the innovation and biological discovery in biomarkers and testing techniques. Join Dr Gareth Blades and Mikhail Zverev from Amati Global Innovation team as they discuss the new opportunities this unlocks for investors.
Dr Paul Jourdan and Gregor Paterson from the Amati UK smallcap team discuss the sentiment towards UK markets, the recent indication from Mansion House Compact that pension funds will be allocating to private markets including AIM, what sectors will be leading the way in the small cap space and what the key themes are likely to be for the second half of 2025.
Geology 101: boots on the ground
Mark and Georges explain the process of conducting a site visit for investment due diligence – by highlighting the site visit to Reunion Gold and G2 Goldfields in Guyana, South America. These 2 investments have returned over 200% investment for the WS Amati Strategic Metals Fund since the site visit.
Finding technology inevitability in an uncertain world.
As the Amati Global Innovation Fund celebrates its 3 year anniversary, the team explains the principles of their investment approach which has enabled them to discover innovation opportunities beyond the ubiquitous mega-cap tech stocks. The brief presentation will include insights into the highest conviction innovation themes in the portfolio, which the team believes are significantly under-appreciated by the market consensus, as well as discussing the current volatile geopolitical and trade environment and the opportunities this presents for long-term investors.
Scott McKenzie, co-manager of the WS Amati UK Listed Smaller Companies, discusses why the asset class has struggled, the early signs of improvement, and what could drive a long-term recovery. We explore volatility, valuations, the impact of government policies like the Mansion House Accord, and the outlook for AIM-listed stocks. With market sentiment shifting and opportunities re-emerging, now might be the time to revisit UK small-caps.
* Registration is required to view this article
Date | Description. |
30/06/2025 | Mikhail Zverev discusses in the following Portfolio Adviser’s article “Avoiding the ‘magnificent seven effect’ and finding the next frontier”. |
06/06/2025 | Graeme Bencke talks defence with Lisa Pham in Bloomberg’s* article “Rheinmetall, Thales, BAE Systems Among European Defense Stock Frenzy Winners”. |
Amati Global Investors Limited
This website is not intended to provide investment, tax or legal advice and none of its content should be construed as a recommendation to buy, sell, or hold, any security, investment product or service. You are solely responsible for determining whether any investment is appropriate for you, based on your investment objectives, financial circumstances and risk tolerance. If you are unsure about the meaning of any information provided, or if you are uncertain as to how to proceed, please consult an independent financial adviser. If you do not have a financial adviser, please contact, where information on finding one can be obtained.
Any research or analysis contained in this website has been prepared or obtained by Amati for its own use. While sources of information are believed to be reliable, no guarantee, warranty or representation is given as to their accuracy or completeness. Investment markets and conditions can change rapidly and as such any views expressed should not be taken as statements of fact nor should reliance be placed on these views when making investment decisions.
By checking the box and proceeding to the website you have confirmed that you have read and understood the information set out below and that you fully understand the risks involved in an investment of this nature.
WS Amati UK Listed Smaller Companies Fund
WS Amati Strategic Metals Fund
WS Amati Global Innovation Fund
Issued by: Amati Global Investors Limited, 8 Coates Crescent, Edinburgh EH3 7AL. Registered in Scotland (company no. SC199908). FCA reference number: 198024
Amati Global Investors is authorised and regulated by the Financial Conduct Authority.
8 Coates Crescent
Edinburgh
EH3 7AL